pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
131
view
list
cards
Preclinical
VS-01
Hyperammonemia
Genfit SA
Phase 1
VS-041
Diastolic Heart Failure (HFpEF)
Vasa Therapeutics SP Zoo
Phase 1
VS-105
Secondary Hyperparathyroidism
Vidasym Inc
Phase 2
← prev
page 147 of 231
next →
Pain
89
Neurology
1
VT-3989
Malignant Pleural Mesothelioma
Vivace Therapeutics Inc
Phase 1
VT-A
Pulmonary Arterial Hypertension
VasThera Co Ltd
Preclinical
VTA-100
Limb-Girdle Muscular Dystrophy
Vita Therapeutics Inc
Preclinical
VTI-1002
Bullous Pemphigoid
viDA Therapeutics Inc
Phase 1
VTP-1000
Celiac Disease
$BRNS
Barinthus Biotherapeutics plc.
Phase 2
VTR-297
Onychomycosis (Tinea Unguium)
$VNDA
Vanda Pharmaceuticals Inc.
Preclinical
VTRU-200
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Vitruviae LLC
Preclinical
VTX-803
Progressive Familial Intrahepatic Cholestasis
Vivet Therapeutics SAS
Preclinical
VTX-806
Cerebrotendinous Xanthomatosis
Vivet Therapeutics SAS
Phase 2
VTx-002
Amyotrophic Lateral Sclerosis
VectorY Therapeutics Inc
VUSION
VUSION (MICONAZOLE NITRATE, ZINC OXIDE, WHITE PETROLATUM)
no indication
MYLAN
Preclinical
VV-169
Refractory Multiple Myeloma
$NVS
NOVARTIS AG
Preclinical
VV-2003
Enterocolitis
Vivreon Biosciences LLC
Preclinical
VV-8325
Alzheimer's Disease
Vivreon Biosciences LLC
Phase 1
VVD-037
Solid Tumor
Vividion Therapeutics Inc
Phase 1
VVD-850
Non-Small Cell Lung Cancer
Vividion Therapeutics Inc
Phase 2
VVN-001
Keratoconjunctivitis Sicca (Dry Eye)
VivaVision Biotech Ltd
Phase 2
VVN-461
Ocular Inflammation
VivaVision Biotech Ltd
Phase 2
VX-407
Polycystic Kidney Disease
$VERX
Vertex, Inc.
Phase 2
VXAG-1.1NN
Norovirus Infections
$VXRT
Vaxart, Inc.
Preclinical
VXAHPV-16.1
Human Papillomavirus (HPV) Associated Cancer
$VXRT
Vaxart, Inc.
Phase 1
VXCO-100
Coronavirus Disease 2019 (COVID-19)
Vaccine Company Inc
Phase 2
VXM-01
Recurrent Glioblastoma Multiforme (GBM)
Vaximm AG
Phase 1
VXS-1219
Influenza A Virus, H7N9 Subtype Infections
Vaxxas Pty Ltd
Preclinical
VY-1706
Alzheimer's Disease
$VYGR
Voyager Therapeutics, Inc.
Phase 2
VY-7523
Alzheimer's Disease
$VYGR
Voyager Therapeutics, Inc.
Phase 1
VYN-202
Fibrosis
$VYNE
VYNE Therapeutics Inc.
